Virginia Tech Carilion (VTC) Innovation Fund
VC Fund
Roanoke, United States
Virginia Tech Carilion (VTC) Innovation Fund is a VC fund in Roanoke focused on Health Care and Biotechnology. The VTC Innovation Fund is a venture capital fund primarily funded by the Virginia Tech Foundation and Carilion Clinic. The Fund is managed by Middleland Capital with the primary goal of investing in rapidly growing companies to create long term value within the Virginia Tech and Carilion Clinic ecosystem. The Fund invests in early stage lifesciences and high growth technology companies. Although the VTC Innovation Fund will focus on Central and Southwest Virginia, it will pursue high growth opportunities across the state of Virginia.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries Virginia Tech Carilion (VTC) Innovation Fund invests in
Stages Virginia Tech Carilion (VTC) Innovation Fund invests in
Countries Virginia Tech Carilion (VTC) Innovation Fund invests in
Investment Focus
Industry
- Health Care 3 (30%)
- Biotechnology 3 (30%)
- Medical 2 (20%)
- Wellness 2 (20%)
- Pharmaceutical 2 (20%)
Stage
- Series A 4 (40%)
- Series B 2 (20%)
- Seed 1 (10%)
- Grant 1 (10%)
- Funding Round 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Acomhal Research
|
Acomhal Research is a biotech startup company that develops novel treatments targeting cancer cells. The company was co-founded by Dr. Samy Lamouille and Dr. Robert Gourdie in 2017 at the Fralin Biomedical Research Institute at Virginia Tech Carilion. | $305K / Grant / Jan 04, 2022 | |
Clean Crop Technologies
|
Clean Crop Technologies is translating groundbreaking research on ways to reduce molds, toxins, and pests into commercial scale services for the global grain and nut sectors. | $6.4M / Series A / Dec 15, 2021 | |
Veralox Therapeutics
|
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients. | $16.6M / Series A / Jun 16, 2021 | |
BRAINBox Solutions
|
BRAINBox provides objective evidence of injury and prediction of patient recovery. BRAINBox Solutions' multi-modality approach is led by the leaders in the industry. It includes blood biomarker panels available on a point of care instrument and standard laboratory systems. | $23M / Series A / Dec 08, 2020 | |
Panaceutics Nutrition
|
Panaceutics Nutrition is a company that produces individually customized smoothies with proprietary cost-effective robotic technology. The company was founded in 2018 by Edison Hudson and Staton Noel and is based in Ringgold, Virginia, United States. | $5M / Series A / Apr 20, 2020 | |
Farmer Focus
|
Founded by sixth-generation farmer Corwin Heatwole in 2014, Farmer Focus is the only 100% USDA organic and Humane Certified® chicken company with a mission to promote and protect generational family farms. By shifting farm-level decision-making and chicken ownership back to farmers and empowering them to farm the way they know is best, Farmer Focussignificantly improves the financial viability of the farm and farmer profit. Available in 2,500 stores throughout the East Coast and Midwest, including major retailers like Publix, Kroger, Harris Teeter and more, Farmer Focus is committed to consistently producing exceedingly delicious, 100% USDA organic and humanely raised chicken that is better for people, the planet and animals. | $15M / Dec 17, 2019 | |
|
Veralox Therapeutics
|
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients. | $5.4M / Seed / Sep 05, 2019 | |
PlanetIQ
|
The need for global atmospheric data has never been greater. The costs of natural disasters are soaring as extreme weather increases and population expands, putting more and more lives and property at risk. Meanwhile, smarter and more powerful weather and climate models are hungry for the data they need to produce more precise forecasts on timescales ranging from hourly to decadal.Yet the traditional model for government-funded satellite programs has not kept up with today’s technology and the rising demand for data. Aging spacecraft, budget constraints and schedule delays threaten critical gaps in data crucial to monitoring and predicting day-to-day weather, hurricanes and winter storms, floods and drought, space weather and climate change. | $18.7M / Series B / Jul 10, 2019 | |
TearSolutions
|
TearSolutions is a pharmaceutical company that specializes in providing medical solutions for dry eyes. The company is driven by its mission is to develop a novel replacement therapy for dry eye through phase II human clinical trials. The platform technology is centered on the remarkable tear protein and the proprietary drug 'Lacripep'.An outsourcing model will be used.The company was founded in Charlottesville, Virginia. | $6.4M / Debt Financing / Mar 21, 2019 | |
|
TearSolutions
|
TearSolutions is a pharmaceutical company that specializes in providing medical solutions for dry eyes. The company is driven by its mission is to develop a novel replacement therapy for dry eye through phase II human clinical trials. The platform technology is centered on the remarkable tear protein and the proprietary drug 'Lacripep'.An outsourcing model will be used.The company was founded in Charlottesville, Virginia. | $8.5M / Series B / Dec 07, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Virginia Tech Carilion (VTC) Innovation Fund invest in?
Virginia Tech Carilion (VTC) Innovation Fund invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Series B stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Virginia Tech Carilion (VTC) Innovation Fund last invest?
The most recent investment recorded for Virginia Tech Carilion (VTC) Innovation Fund closed in Jan 2022. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
